Methotrexate toxicity presenting as ulceration of psoriatic plaques: A report of two cases

Indian Journal of Dermatology, Venereology and Leprology

Volumn 74, Issue 5, 2008, Pages 481-484

  Agarwal, Kishan ^a   Nath, Amiya ^a   Thappa, Devinder ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Methotrexate toxicity; Psoriasis; Skin ulceration

Indexed keywords

CEFTAZIDIME; FLUCONAZOLE; FOLINATE CALCIUM; METHOTREXATE; POVIDONE IODINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SULFADIAZINE SILVER;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; DRUG INTERMITTENT THERAPY; HUMAN; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PSORIASIS; SELF MEDICATION; SKIN CARE; SKIN ULCER; STOMACH EROSION;

EID: 57449096543     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.44305     Document Type: Article

References (16)

1. nd ed. Edinburgh: Churchill-Livingstone; 1999. p. M90-6.
2. Roenigk HH Jr, Auerbach R, Maiback HI, Weinstein GD. Methotrexate in psoriasis: Revised guidelines. J Am Acad Dermatol 1988;19:145-56.
3. Pearce HP, Wilson BB. Erosion of psoriatic plaques: An early sign of methotrexate toxicity. J Am Acad Dermatol 1996;35:835-8.
4. th ed. New York: McGraw-Hill; 2003. p. 2398-409.
5. Lawrence CM, Dahl MG. Two patterns of skin ulceration induced by methotrexate in patients with psoriasis. J Am Acad Dermatol 1984;11:1059-65.
6. Kaplan DL, Olsen EA. Erosion of psoriatic plaques after chronic methotrexate administration. Int J Dermatol 1988;27:59-62.
7. Reed KM, Sober AJ. Methotrexate-induced necrolysis. J Am Acad Dermatol 1983;8:677-9.
8. Kazlow DW, Federgrun D, Kurtin S, Lebwohl MG. Cutaneous ulceration caused by methotrexate. J Am Acad Dermatol 2003;49:S197-8.
9. Daly HM, Scott GL, Boyle J, Roberts CJ. Methotrexate toxicity precipitated by azapropazone. Br J Dermatol 1986;114:733-5.
10. Groenendal H, Rampen FH. Methotrexate and trimethoprim- sulphamethoxazole: A potentially hazardous combination. Clin Exp Dermatol 1990;15:358-60.
11. Ng HW, Macfarlane AW, Graham RM, Verbov JL. Near fatal drug interactions with methotrexate given for psoriasis. Br Med J (Clin Res Ed) 1987;295:752-3.
12. Bleyer WA. Methotrexate: Clinical pharmacology, current status and therapeutic guidelines. Cancer Treat Rev 1977;4:87-101.
13. Hoffman TE, Watson W. Methotrexate toxicity in the treatment of generalized pustular psoriasis. Cutis 1978;21:68-71.
14. Campalani E, Arenas M, Marinaki AM, Lewis CM, Barker JN, Smith CH. Polymorphisms in folate, pyrimidine and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis. J Invest Dermatol 2007;127:1860-7.
15. Shupack JL, Webster GF. Pancytopenia following low-dose oral methotrexate therapy for psoriasis. JAMA 1988;259:3594-6.
16. Patekar MN, Dongre AM, Gogtay NJ, Khopkar US, Kshirsagar NA. A patient with accidental methotrexate overdose: A case of medication error, a preventable adverse event. Adverse drug event of the month March 2005. [last accessed on 2008 Mar] Available from: http://www.kem.edu/dept/clinical_pharmacology/ adverse_event_month_case/case_march2005.htm.